Illinois Invokana Lawsuit Plaintiff Claims Drug Caused Devastating Kidney Failure Side Effects

February 24, 2016 - PRESSADVANTAGE -

TheProductLawyers.com reports on a lawsuit filed against Janssen Pharmaceuticals, a division of corporate giant Johnson & Johnson, and manufacturer of new-generation type-2 diabetes drug Invokana, as well as Mitsubishi Tanabe Pharma Corporation. The lawsuit was filed on October 28th of 2015 by a man from Illinois, and is now listed under case number 3:15-cv-01195 in the U.S. District Court for the Southern District of Illinois, East St. Louis Division. Details of the suit show that the plaintiff alleges that each defendant is responsible for the injuries he suffered while using Invokana. He is now seeking more than $75k in damages as his lawsuit involves multiple counts, including negligence, misrepresentation, fraud, product liability, defective design, and breach of warranties.

The plaintiff indicates that he was prescribed the drug in February of 2015 in order to help him manage his blood sugar (glucose) levels. The drug works to help manage these sugar levels by excreting excess sugar through urination. The man alleges that, due to this fact, the drug put extreme stress on his kidney, and that, rather than helping improve his condition, it caused him severe and irreparable kidney damage. He states that he chose to use the drug because he relied on information provided by the defendants which assured him that Invokana was both an effective and safe option. Today, he says that these claims were misleading, and that the companies failed to adequately inform both he and his physician about the risks associated with their drug.

Invokana was approved by the U.S. Food and Drug Administration (FDA) in February of 2013 to treat patients with type-2 diabetes. It was released as one of several type-2 diabetes drugs in the sodium-glucose cotransporter-2 class (also known as SGLT2 inhibitors). Clinical studies have linked the drug to several potential side effects, such as urinary tract infections which can lead to more severe kidney and blood infections.

In addition, Invokana has allegedly been linked to a potentially life-threatening condition called diabetic ketoacidosis, which develops when the body’s bloodstream develops too much acid. The acid is from ketones (also known as fatty acids) which are released and able to enter the body’s bloodstream, causing a toxic imbalance of chemicals. The condition can develop in less than 24 hours and cause patients to enter a comatose state or even die if left untreated.

On December 4th of 2015, the FDA required that Invokana manufacturer Janssen Pharmaceuticals make changes to the current warning label on Invokana to better inform the public of this potential link to ketoacidosis and urinary tract infections (UTI). This move followed many adverse event reports to the FDA indicating that patients using the drug had suffered from these conditions.

The attorneys at Banville Law understand how serious these potentially linked side effects can be, and are well aware of the volume of patients across the U.S. who depend on Invokana or other SGLT2 inhibitor medications to manage their diabetes. Banville Law sponsors TheProductLawyers.com, an online resource for anyone looking to obtain up to date and important Invokana information. Currently, the attorneys at Banville Law are working to help ensure that anyone who has used these types of drugs and who also suffered from serious health problems will be provided the opportunity to investigate their legal rights completely. To help those who may need assistance seeking justice, the attorneys of Banville Law are offering complimentary legal consultations for involved parties at this time.

To request further information, or to ask questions, contact the attorneys at Banville Law by calling 877-671-6480.

###

For more information about TheProductLawyers.com, contact the company here:

TheProductLawyers.com
Banville Law
888-478-9711
info@banvillelaw.com
165 West End Ave #1h,
New York, NY 10023